69 related articles for article (PubMed ID: 3602316)
21. [Impulsive dyssocial borderline personalities--psychogenesis, regression, therapy and expert assessment].
von Held HR
Psychother Psychosom Med Psychol; 1987 Nov; 37(11):389-93. PubMed ID: 3685241
[No Abstract] [Full Text] [Related]
22. [Effect of tranquilizers on short-term memory in patients with borderline forms of neuropsychiatric disorders].
Maksimenko TV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(5):737-40. PubMed ID: 6880505
[TBL] [Abstract][Full Text] [Related]
23. [Pathologic personality, temperament and treatment].
Akiskal HS
Encephale; 1995 Mar; 21 Spec No 2():47-9. PubMed ID: 7588180
[TBL] [Abstract][Full Text] [Related]
24. Risperidone treatment of borderline personality disorder assessed by a borderline personality disorder-specific outcome measure: a pilot study.
Friedel RO; Jackson WT; Huston CS; May RS; Kirby NL; Stoves A
J Clin Psychopharmacol; 2008 Jun; 28(3):345-7. PubMed ID: 18480695
[No Abstract] [Full Text] [Related]
25. Pharmacotherapy for patients with borderline personality disorder.
Goldberg SC; Schulz SC
Arch Gen Psychiatry; 1988 Feb; 45(2):195-6. PubMed ID: 2892479
[No Abstract] [Full Text] [Related]
26. Specifying the impulsivity of female inmates with borderline personality disorder.
Hochhausen NM; Lorenz AR; Newman JP
J Abnorm Psychol; 2002 Aug; 111(3):495-501. PubMed ID: 12150425
[TBL] [Abstract][Full Text] [Related]
27. Psychopharmacologic management of patients with borderline personality disorder.
Links PS; Steiner M
Can J Psychiatry; 1988 Jun; 33(5):355-9. PubMed ID: 3044565
[TBL] [Abstract][Full Text] [Related]
28. Drug therapy in borderline patients.
Cole JO; Salomon M; Gunderson J; Sunderland P; Simmonds P
Compr Psychiatry; 1984; 25(3):249-54. PubMed ID: 6145541
[No Abstract] [Full Text] [Related]
29. Levodopa in borderline disorders.
Bonnet KA; Redford HR
Arch Gen Psychiatry; 1982 Jul; 39(7):862. PubMed ID: 7165486
[No Abstract] [Full Text] [Related]
30. A dramatic behavioral response to thyrotropin-releasing hormone following low-dose neuroleptics.
Garbutt JC; Loosen PT
Psychoneuroendocrinology; 1984; 9(3):311-4. PubMed ID: 6436858
[TBL] [Abstract][Full Text] [Related]
31. What dimensions underlie cluster B personality disorders?
Looper KJ; Paris J
Compr Psychiatry; 2000; 41(6):432-7. PubMed ID: 11086148
[TBL] [Abstract][Full Text] [Related]
32. An open trial of valproate in borderline personality disorder.
Stein DJ; Simeon D; Frenkel M; Islam MN; Hollander E
J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502
[TBL] [Abstract][Full Text] [Related]
33. Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.
Schatzberg AF; Cole JO
Br J Clin Pharmacol; 1981; 11 Suppl 1(Suppl 1):17S-22S. PubMed ID: 6133529
[No Abstract] [Full Text] [Related]
34. m-Chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures.
Stein DJ; Hollander E; DeCaria CM; Simeon D; Cohen L; Aronowitz B
Biol Psychiatry; 1996 Sep; 40(6):508-13. PubMed ID: 8879471
[TBL] [Abstract][Full Text] [Related]
35. [Alternative therapy with noxiptilin and amitriptyline in clinical-stationary treated depression].
Voelkel A
Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:901+. PubMed ID: 5819771
[No Abstract] [Full Text] [Related]
36. Stelazine advertisement "dismays" readers.
Swartz M; Taska R; Hargett A; Noll B; Fraker W
Am J Psychiatry; 1985 May; 142(5):666. PubMed ID: 3985219
[No Abstract] [Full Text] [Related]
37. Pharmacologic management of borderline personality disorder: a case study.
Links PS; Cook M; Quastel A
Essent Psychopharmacol; 2005; 6(6):319-30. PubMed ID: 16459755
[TBL] [Abstract][Full Text] [Related]
38. The successful pharmacological treatment of adolescents and young adults with borderline personality disorder: a preliminary open trial of flupenthixol.
Kutcher S; Papatheodorou G; Reiter S; Gardner D
J Psychiatry Neurosci; 1995 Mar; 20(2):113-8. PubMed ID: 7703220
[TBL] [Abstract][Full Text] [Related]
39. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cognitive-perceptual, affective, and impulsive-behavioral dysregulation.
Soloff PH
Bull Menninger Clin; 1998; 62(2):195-214. PubMed ID: 9604516
[TBL] [Abstract][Full Text] [Related]
40. Imipramine treatment of borderline children: case reports with a controlled study.
Petti TA; Unis A
Am J Psychiatry; 1981 Apr; 138(4):515-8. PubMed ID: 7011062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
